BR0311511A - Preparações farmacêuticas para a aplicação oral contendo resinas trocadoras de ìons carregadas com substância ativa bem como formadores de gel de estrutura viscosa como espessante - Google Patents

Preparações farmacêuticas para a aplicação oral contendo resinas trocadoras de ìons carregadas com substância ativa bem como formadores de gel de estrutura viscosa como espessante

Info

Publication number
BR0311511A
BR0311511A BR0311511-9A BR0311511A BR0311511A BR 0311511 A BR0311511 A BR 0311511A BR 0311511 A BR0311511 A BR 0311511A BR 0311511 A BR0311511 A BR 0311511A
Authority
BR
Brazil
Prior art keywords
pharmaceutical preparations
oral application
well
active substance
ion exchange
Prior art date
Application number
BR0311511-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Dirk Mertin
Markus Edingloh
Gert Daube
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of BR0311511A publication Critical patent/BR0311511A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR0311511-9A 2002-05-31 2003-05-19 Preparações farmacêuticas para a aplicação oral contendo resinas trocadoras de ìons carregadas com substância ativa bem como formadores de gel de estrutura viscosa como espessante BR0311511A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10224086A DE10224086A1 (de) 2002-05-31 2002-05-31 Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
PCT/EP2003/005228 WO2003101422A2 (de) 2002-05-31 2003-05-19 Pharmazeutiche zubereitungen zur oralen anwendung enthaltend wirkstoffbeladene ionentauscherharze sowie strukturviskose gelbildner als verdicker

Publications (1)

Publication Number Publication Date
BR0311511A true BR0311511A (pt) 2005-02-22

Family

ID=29432468

Family Applications (2)

Application Number Title Priority Date Filing Date
BR0311511-9A BR0311511A (pt) 2002-05-31 2003-05-19 Preparações farmacêuticas para a aplicação oral contendo resinas trocadoras de ìons carregadas com substância ativa bem como formadores de gel de estrutura viscosa como espessante
BRPI0311511-9A BRPI0311511B1 (pt) 2002-05-31 2003-05-19 "preparações farmacêuticas líquidas, e sua aplicação".

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0311511-9A BRPI0311511B1 (pt) 2002-05-31 2003-05-19 "preparações farmacêuticas líquidas, e sua aplicação".

Country Status (27)

Country Link
US (1) US8545829B2 (enExample)
EP (1) EP1513500B1 (enExample)
JP (2) JP5350574B2 (enExample)
KR (3) KR20120123607A (enExample)
CN (1) CN1671361B (enExample)
AR (2) AR039861A1 (enExample)
AT (1) ATE421317T1 (enExample)
AU (1) AU2003242545B2 (enExample)
BR (2) BR0311511A (enExample)
CA (1) CA2487648C (enExample)
CR (1) CR7598A (enExample)
DE (2) DE10224086A1 (enExample)
DK (1) DK1513500T3 (enExample)
ES (1) ES2319115T3 (enExample)
HR (1) HRP20041219B1 (enExample)
IL (2) IL165322A0 (enExample)
MX (1) MXPA04011820A (enExample)
MY (1) MY140953A (enExample)
NO (1) NO333939B1 (enExample)
PL (1) PL207269B1 (enExample)
PT (1) PT1513500E (enExample)
RU (1) RU2380091C2 (enExample)
SI (1) SI1513500T1 (enExample)
TW (1) TWI333422B (enExample)
UA (1) UA84270C2 (enExample)
WO (1) WO2003101422A2 (enExample)
ZA (1) ZA200409616B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
WO2006061700A2 (en) * 2004-12-06 2006-06-15 Themis Laboratories Private Limited Rapid disintegrating taste masked compositions and a process for its preparations
DE102005025900A1 (de) * 2005-06-06 2006-12-07 Basf Ag Verfahren zur Entfernung von Salzen aus einem Alkoxycarbonylaminotriazin enthaltenden Reaktionsgemisch
US20080051332A1 (en) * 2005-11-18 2008-02-28 Nastech Pharmaceutical Company Inc. Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
CN100360131C (zh) * 2006-01-24 2008-01-09 新昌国邦化学工业有限公司 一种掩味恩诺沙星的生产方法
US20070248564A1 (en) * 2006-04-25 2007-10-25 Roxane Laboratories, Inc. Formulation of sodium polystyrene sulfonate suspension for the treatment of hyperkalemia
CN103349659A (zh) * 2006-09-26 2013-10-16 塔罗制药北美有限公司 液体药物组合物以及应用
DE102006049520A1 (de) 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
US20080118570A1 (en) * 2006-11-20 2008-05-22 Zhi Liu Polymer coated drug-ion exchange resins and methods
CN103550214A (zh) * 2008-03-26 2014-02-05 塔罗制药北美有限公司 用于口服药剂的稳定脂质组合物
PL2544532T3 (pl) 2010-03-12 2017-08-31 Monsanto Technology Llc Agrochemiczne kompozycje żelowe
EA023294B1 (ru) * 2010-05-19 2016-05-31 Астеллас Фарма Инк. Фармацевтическая композиция, содержащая солифенацин
BR112014009547A8 (pt) 2011-10-19 2018-01-23 Scherer Technologies Llc R P composição farmacêutica para administração oral, e, sistema de liberação para a administração oral de uma composição farmacêutica bifásica
FR2998305B1 (fr) * 2012-11-22 2015-02-20 Henkel Ag & Co Kgaa Substances actives contenant des groupes sulfonates ameliorant la puissance de lavage primaire
KR101697095B1 (ko) * 2015-09-30 2017-01-18 주식회사 포스코 더스트 막힘을 방지할 수 있는 배가스 청정 라인의 실탱크
ES2956316T3 (es) 2018-04-25 2023-12-19 Elanco Animal Health Gmbh Proceso para la hidrólisis de ésteres carboxílicos de quinolona
KR102923598B1 (ko) * 2019-07-15 2026-02-09 한미약품 주식회사 몬테루카스트 또는 이의 약학적으로 허용가능한 염을 포함하는 액상 시럽제제 및 이의 제조방법
CN114249749B (zh) * 2022-01-08 2024-03-22 天象生物药业邢台有限责任公司 一种马波沙星甲酸盐的转化方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US614622A (en) * 1898-11-22 Machine for making billets
JPS60204713A (ja) 1984-03-30 1985-10-16 Zenyaku Kogyo Kk 水性懸濁組成物
GB8618847D0 (en) 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
US5338732A (en) 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
FI941941L (fi) * 1991-10-28 1994-04-27 Procter & Gamble Sakeutus-emulgointiainejärjestelmä juomia varten
JP3207494B2 (ja) 1992-04-02 2001-09-10 ロート製薬株式会社 水性懸濁製剤
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
PL186737B1 (pl) * 1996-02-23 2004-02-27 Bayer Ag Kwasy 8-cyjano-1-cyklopropylo-7-/2, 8-diazabicyklo [ 4.3.0 ] nonan-8-ylo/-6-fluoro-1,4-dihydro-4-okso-3-chinolinokarboksylowe i ich pochodne, sposób ich wytwarzania, środki medyczne je zawierające i ich zastosowanie do wytwarzania środków medycznychi antybakteryjnych
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DK1200129T3 (da) * 1999-07-14 2009-01-12 Schering Plough Ltd Smagsmaskering af orale, flydende quinolonfremstillinger ved anvendelse af ionbytterharpikser
GB9930058D0 (en) 1999-12-20 2000-02-09 Novartis Ag Organic compounds
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
DE10134719A1 (de) * 2001-07-17 2003-02-06 Bayer Ag Pharmazeutische Zubereitungen enthaltend wirkstoffbeladene Ionentauscherharze
US7001667B2 (en) * 2002-07-17 2006-02-21 Ppg Industries Ohio, Inc. Alkyd-based free radical wood coating compositions

Also Published As

Publication number Publication date
PT1513500E (pt) 2009-04-02
US20060177414A1 (en) 2006-08-10
CR7598A (es) 2008-07-31
RU2004139022A (ru) 2005-07-10
EP1513500A2 (de) 2005-03-16
WO2003101422A2 (de) 2003-12-11
CN1671361B (zh) 2010-05-12
TW200406230A (en) 2004-05-01
TWI333422B (en) 2010-11-21
HRP20041219B1 (hr) 2013-05-31
AR105798A2 (es) 2017-11-08
BRPI0311511A8 (pt) 2017-07-11
BRPI0311511B1 (pt) 2018-07-10
MY140953A (en) 2010-02-12
JP5350574B2 (ja) 2013-11-27
ATE421317T1 (de) 2009-02-15
IL165322A (en) 2015-11-30
ZA200409616B (en) 2006-05-31
NO333939B1 (no) 2013-10-28
EP1513500B1 (de) 2009-01-21
JP2006503806A (ja) 2006-02-02
KR20050010015A (ko) 2005-01-26
UA84270C2 (ru) 2008-10-10
BRPI0311511A (enExample) 2005-02-22
WO2003101422A3 (de) 2004-12-09
KR20120006092A (ko) 2012-01-17
CN1671361A (zh) 2005-09-21
US8545829B2 (en) 2013-10-01
HK1083200A1 (en) 2006-06-30
RU2380091C2 (ru) 2010-01-27
AR039861A1 (es) 2005-03-02
DE10224086A1 (de) 2003-12-11
PL373456A1 (en) 2005-08-22
CA2487648C (en) 2012-03-13
ES2319115T3 (es) 2009-05-04
AU2003242545B2 (en) 2010-02-18
IL165322A0 (en) 2006-01-15
KR101258373B1 (ko) 2013-04-30
CA2487648A1 (en) 2003-12-11
MXPA04011820A (es) 2005-03-31
PL207269B1 (pl) 2010-11-30
KR20120123607A (ko) 2012-11-08
NO20045700L (no) 2004-12-29
AU2003242545A1 (en) 2003-12-19
HRP20041219A2 (en) 2006-02-28
DK1513500T3 (da) 2009-05-11
JP2011012087A (ja) 2011-01-20
DE50311123D1 (de) 2009-03-12
SI1513500T1 (sl) 2009-06-30

Similar Documents

Publication Publication Date Title
BRPI0311511A8 (pt) "preparações farmacêuticas líquidas, e sua aplicação".
BR0114927A (pt) Composição de gel farmacêutica substancialmente não aquosa para aplicação na pele, e, uso da composição
BR0207726A (pt) Sais farmacêuticos
TR199500825A2 (tr) Cok üniteli farmasötik müstahzar.
BRPI0411982A (pt) glicano de aperfeiçoamento de terapia
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
BR0100046A (pt) Copolìmeros reticulados solúveis em água ou intumescìveis em água
BR9815570A (pt) Composto, processo de preparação dos compostos, utilização de pelo menos um composto, composição cosmética ou farmacêutica e utilização de pelos menos um polìmero
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
BR0015048A (pt) Sal farmacêutico, medicamento, uso de pelo menos um sal de tramadol e formas de apresentação
BR9801652A (pt) Resorcinil-triazinas
BRPI0013010B8 (pt) formulação aquosa de cloreto de sódio de moxifloxacina, processo para sua preparação e aplicação da referida formulação, bem como preparado de combinação e aplicação de uma solução aquosa de cloridrato de moxifloxacina
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
BR0014946A (pt) Uso de dipiridamol ou mopidamol na fabricação de um medicamento para o tratamento e prevenção de distúrbios da microcirculação dependentes da fibrina
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
ATE231852T1 (de) Bicyclische aromatische verbindungen
BR9812553A (pt) Formulação medicamentosa com liberação de substância ativa controlada
BR0014826A (pt) Imidazo-3-il-aminas bicìclicas, procedimento de sua preparação e medicamentos que as contêm
EA199700381A1 (ru) Диароматические соединения пропинила или диенила, промежуточные соединения, фармацевтические и косметические композиции на основе указанных соединений и применение косметических композиций
BR0311154A (pt) Composição para melhorar o melasma e composição para reduzir a opacidade da pele
DE50310486D1 (de) Lipid-transferprotein - systeme und deren kosmetische dermatologische anwendung
BR9612287A (pt) Emprego de inibidores de troca de na+ /h+ (nhe) celular para a preparação de um medicamento para estimular a respiração
BR0312318A (pt) Compostos, uso de um ou mais compostos, composição farmacêutica, composição cosmética e usos cosméticos
BR9904890A (pt) "compostos de heteroetinileno, composição farmacêutica, composição cosmética e utilização de uma composição cosmética"
BRPI0611526A2 (pt) composição tópica contendo gelatina

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BAYER ANIMAL HEALTH GMBH (DE)

Free format text: TRANSFERIDO DE: BAYER HEALTHCARE AG

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 9/10, 47/48, 31/44, 31/4709; A61P 31/00

Ipc: A61K 9/10 (2011.01), A61K 47/48 (2011.01), A61K 31

B25A Requested transfer of rights approved

Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 9/10 , A61K 47/48 , A61K 31/44 , A61K 31/4709 , A61P 31/00

Ipc: A61K 9/10 (2006.01), A61K 31/44 (2006.01), A61K 31

Ipc: A61K 9/10 (2006.01), A61K 31/44 (2006.01), A61K 31

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]